Skip to main content

Find Clinical Trials

Clinical trial condition

NSCLC

Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.

357 public trials 121 recruiting studies

Refine in advanced search Browse all conditions

NSCLC trial results

Completed

A Phase I Study to Determine the Effect of Food on the Pharmacokinetic Profile of BPI-7711

NCT04135820

Conditions: NSCLC
Locations: Shanghai Ninth People's Hospital Shanghai, China

View Trial Details

Completed

A Rollover Protocol of Dacomitinib For Patients In Japan

NCT02382796

Conditions: NSCLC
Locations: Kanazawa University Hospital Kanazawa, Ishikawa-ken, Japan

Kurashiki Central Hospital Kurashiki, Okayama-ken, Japan

Osaka City General Hospital Department of Clinical Oncology Osaka, Japan

Kindai University Hospital Sayama, Osaka, Japan

View Trial Details

Completed

ATOM_local Ablative Therapy

NCT01941654

Conditions: Activating EGFR Mutation, NSCLC
Locations: Department of Clinical Oncology Hong Kong

View Trial Details

Completed

Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLC

NCT01562210

Conditions: NSCLC
Locations: Netherlands Cancer Institute - Antoni van Leeuwenhoek Ziekenhuis (NKI-AVL) Amsterdam, North Holland, Netherlands

View Trial Details

Completed

Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma

NCT04276025

Conditions: Lung Diseases, Lung Neoplasms, NSCLC, +5 more
Locations: Not specified

View Trial Details

Completed

A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid Tumors

NCT02563548

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Clinic, Scottsdale, Arizona Scottsdale, Arizona, United States

California Cancer Associates for Research and Excellence - Encinitas Encinitas, California, United States

University of California San Diego - Moores Cancer Center La Jolla, California, United States

View all 28 locations

View Trial Details

Completed

A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer

NCT02976116

Conditions: NSCLC
Locations: Shanghai Chest Hospital Shanghai, Shanghai Municipality, China

The First Hospital of Zhejiang University Hangzhou, China

View Trial Details

Completed

A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer

NCT02000947

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Research Site Birmingham, Alabama, United States

Research Site Tucson, Arizona, United States

Research Site Los Angeles, California, United States

Research Site Los Angeles, California, United States

View all 69 locations

View Trial Details

Completed

Lung HeXeRT: Helium, Xenon MRI for NSCLC Patients

NCT01859650

Conditions: NSCLC
Locations: Sheffield Teaching Hospitals Sheffield, United Kingdom

View Trial Details

Completed

Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)

NCT00153803

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Birmingham Hematology and Oncology Associates, LLC Birmingham, Alabama, United States

Oncology Specialties, P.C. Huntsville, Alabama, United States

Cooper Clinic Fort Smith, Arkansas, United States

Genesis Cancer Center Hot Springs, Arkansas, United States

View all 65 locations

View Trial Details